Project Start
1992-04-01
Project End
1995-11-30
Budget Start
1992-09-10
Budget End
1993-03-31
Support Year
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Istituto Superiore Di Sanita
Department
Type
DUNS #
City
Rome
State
Country
Italy
Zip Code
Tozzi, Alberto E; Rava, Lucilla; Ciofi degli Atti, Marta L et al. (2003) Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life. Pediatrics 112:1069-75
Tozzi, A E; Anemona, A; Stefanelli, P et al. (2001) Reactogenicity and immunogenicity at preschool age of a booster dose of two three-component diphtheria-tetanus-acellular pertussis vaccines in children primed in infancy with acellular vaccines. Pediatrics 107:E25
Salmaso, S; Mastrantonio, P; Tozzi, A E et al. (2001) Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 108:E81
Stefanelli, P; De Marzi, L; Robino, L et al. (1999) Characterization of Bordetella pertussis strains of recent isolation. New Microbiol 22:187-94
Mastrantonio, P; Spigaglia, P; van Oirschot, H et al. (1999) Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 145 ( Pt 8):2069-75
Ciofi degli Atti, M; Anemona, A; Tozzi, A E et al. (1999) Reactogenicity of a three-dose pertussis acellular vaccine catch-up in children 21-40 months of age. Vaccine 17:2030-5
Giuliano, M; Mastrantonio, P; Giammanco, A et al. (1998) Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr 132:983-8
Tozzi, A E; Ciofi degli Atti, M L; Wassilak, S G et al. (1998) Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccines. Vaccine 16:320-2
Salmaso, S; Mastrantonio, P; Wassilak, S G et al. (1998) Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group. Vaccine 16:1270-5
Greco, D; Salmaso, S; Mastrantonio, P et al. (1996) A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med 334:341-8